SCHEMBL22047535

SCHEMBL22047535

OCCCOC1CN(I)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18551472 0.78 SMN1; SMN2 (0.32) —
SCHEMBL22906880 0.77 — —
SCHEMBL10684690 0.74 NPC1 (0.33) —
SCHEMBL10040755 0.74 — —
SCHEMBL470896 0.74 — —
SCHEMBL22047550 0.74 — —
SCHEMBL22464565 0.74 PDK2 (0.32) —
SCHEMBL1444884 0.70 NPC1 (0.45) —
SCHEMBL19250886 0.69 — —
SCHEMBL386704 0.68 NPC1 (0.48) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3512842-B1 INDOLE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS ARVINAS INC (US) 2024-01-17 — — EP disclosed
EP-3689868-A1 TETRAHYDRONAPHTHALENE AND TETRAHYDROISOQUINOLINE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS Arvinas Operations, Inc. (US) 2020-08-05 — — EP disclosed
EP-3660004-A1 COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR Arvinas Operations, Inc. (US) 2020-06-03 — — EP disclosed
Send feedback